Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells.
Riza SerttasSuat ErdoganPublished in: Anti-cancer agents in medicinal chemistry (2023)
Based on our findings, triapine emerges as a promising chemotherapeutic approach for combating docetaxel-resistant prostate cancer.